{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:33:51Z","timestamp":1786988031897,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ejca.2020.08.031","type":"journal-article","created":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T10:17:40Z","timestamp":1602152260000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients"],"prefix":"10.1016","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5876-6696","authenticated-orcid":false,"given":"Constantine","family":"Alifrangis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shafi","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Milic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gogbashian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samita","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Sahdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Harland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Stoneham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lockley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Rustin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5474-8696","authenticated-orcid":false,"given":"Daniel","family":"Berney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Shamash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejca.2020.08.031_bib1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1200\/JCO.1989.7.3.387","article-title":"Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol","volume":"7","author":"Einhorn","year":"1989","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2020.08.031_bib2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1200\/JCO.1998.16.2.702","article-title":"Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience","volume":"16","author":"Saxman","year":"1998","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2020.08.031_bib3","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1200\/JCO.1998.16.4.1287","article-title":"Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study","volume":"16","author":"Nichols","year":"1998","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2020.08.031_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/annonc\/mdx731","article-title":"Multidisciplinary clinic approach improves overall survival outcomes of patients with metastatic germ-cell tumors","volume":"29","author":"Albany","year":"2018","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2020.08.031_bib5","first-page":"653","article-title":"The management of advanced germ cell tumors in 2016: the memorial sloan kettering approach","volume":"30","author":"Funt","year":"2016","journal-title":"Oncology (Williston Park)"},{"issue":"33","key":"10.1016\/j.ejca.2020.08.031_bib6","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1200\/JCO.2007.15.9103","article-title":"Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study","volume":"26","author":"Garcia-del-Muro","year":"2008","journal-title":"J Clin Oncol"},{"issue":"36","key":"10.1016\/j.ejca.2020.08.031_bib7","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1200\/JCO.2005.03.6616","article-title":"Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors","volume":"23","author":"Kondagunta","year":"2005","journal-title":"J Clin Oncol"},{"issue":"36","key":"10.1016\/j.ejca.2020.08.031_bib8","doi-asserted-by":"crossref","first-page":"9130","DOI":"10.1200\/JCO.2005.01.4092","article-title":"Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer","volume":"23","author":"Nuver","year":"2005","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.ejca.2020.08.031_bib9","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1200\/JCO.2005.02.176","article-title":"The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer","volume":"23","author":"Nuver","year":"2005","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.ejca.2020.08.031_bib10","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/jnci\/dji278","article-title":"Second cancers among 40,576 testicular cancer patients: focus on long-term survivors","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"23","key":"10.1016\/j.ejca.2020.08.031_bib11","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1200\/JCO.2016.66.8822","article-title":"Comprehensive audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer","volume":"34","author":"Frisina","year":"2016","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1016\/j.ejca.2020.08.031_bib12","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1200\/JCO.2017.77.0735","article-title":"Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study","volume":"36","author":"Kerns","year":"2018","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.ejca.2020.08.031_bib13","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/jnci\/djq245","article-title":"Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial","volume":"102","author":"Grimison","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.ejca.2020.08.031_bib14","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/sj.bjc.6602020","article-title":"Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials","volume":"91","author":"Bokemeyer","year":"2004","journal-title":"Br J Canc"},{"issue":"8","key":"10.1016\/j.ejca.2020.08.031_bib15","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/annonc\/mdq300","article-title":"Single-agent carboplatin AUC10 for metastatic seminoma with IGCCCG good prognosis disease; a feasibility study of the Orchid Clinical Trials Group","volume":"21","author":"Matakidou","year":"2010","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2020.08.031_bib16","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3109\/0284186X.2012.714078","article-title":"Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma","volume":"52","author":"Tookman","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ejca.2020.08.031_bib17","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejca.2019.04.013","article-title":"A phase II study of carboplatin AUC-10 guided by positron emission tomography-defined metabolic response in metastatic seminoma","volume":"115","author":"Shamash","year":"2019","journal-title":"Eur J Canc"},{"issue":"1","key":"10.1016\/j.ejca.2020.08.031_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.21873\/invivo.11465","article-title":"A qualitative analysis of the impact of carboplatin AUC 10 on physical, work functioning and bone marrow toxicity among seminoma patients - a single-centre experience","volume":"33","author":"Milic","year":"2019","journal-title":"Vivo"},{"issue":"4","key":"10.1016\/j.ejca.2020.08.031_bib19","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/annonc\/mdu447","article-title":"Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma: a systematic review and meta-analysis of patient outcomes","volume":"26","author":"Giannatempo","year":"2015","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2020.08.031_bib20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/annonc\/mdj039","article-title":"Single agent carboplatin for CS IIA\/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG)","volume":"17","author":"Krege","year":"2006","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2020.08.031_bib21","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/annonc\/mdu506","article-title":"Renal impairment and late toxicity in germ-cell cancer survivors","volume":"26","author":"Lauritsen","year":"2015","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2020.08.031_bib22","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1093\/annonc\/mdx071","article-title":"A randomized phase III study of 72 h infusional versus bolus bleomycin in BEP (bleomycin, etoposide and cisplatin) chemotherapy to treat IGCCCG good prognosis metastatic germ cell tumours (TE-3)","volume":"28","author":"Shamash","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2020.08.031_bib23","doi-asserted-by":"crossref","first-page":"8781698","DOI":"10.1155\/2018\/8781698","article-title":"Adjuvant therapy for stage IB germ cell tumors: one versus two cycles of BEP","volume":"2018","author":"Huddart","year":"2018","journal-title":"Adv Urol"},{"issue":"4","key":"10.1016\/j.ejca.2020.08.031_bib24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.6004\/jnccn.2012.0052","article-title":"Second malignant neoplasms in testicular cancer survivors","volume":"10","author":"Fung","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"issue":"16","key":"10.1016\/j.ejca.2020.08.031_bib25","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/jnci\/djm081","article-title":"Comparative mortality for 621 second cancers in 29356 testicular cancer survivors and 12420 matched first cancers","volume":"99","author":"Schairer","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ejca.2020.08.031_bib26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/annonc\/mdm540","article-title":"The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the testis","volume":"19","author":"Powles","year":"2008","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2020.08.031_bib27","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM199902043400504","article-title":"Risk of leukemia after platinum-based chemotherapy for ovarian cancer","volume":"340","author":"Travis","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2020.08.031_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejca.2019.05.001","article-title":"Results from the UK Children's Cancer and Leukaemia Group study of extracranial germ cell tumours in children and adolescents (GCIII)","volume":"118","author":"Depani","year":"2019","journal-title":"Eur J Canc"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492030486X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980492030486X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:35:20Z","timestamp":1760733320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980492030486X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":28,"alternative-id":["S095980492030486X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2020.08.031","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2020.08.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}